GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.
The Dawn of a New Era in Alzheimer’s Care: From Simple Blood Tests to At-Home Treatments
Discover how the new p-tau217 blood test and the LEQEMBI IQLIK® autoinjector are revolutionizing Alzheimer's diagnosis and treatment at home.
A Turning Point in the Fight Against Alzheimer's
For decades, the search for an Alzheimer's cure focused almost entirely on one thing: clearing out a protein called amyloid that builds up in the brain. But as we move through 2026, the landscape of medical research is undergoing a massive and hopeful transformation.